442-D OUTLAST™ CAR-T cells exhibit superior effector function against solid tumors
Main Authors: | Sumiti Jain, Jessica Pafford, Matthew Esquivel, Adam Pecoraro, Warren Anderson, Kevin Carbajal, Prasanna Ekambaram |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
442-C A best-in-class HSC-derived CAR-Monocyte product with a novel CAR costimulatory domain significantly improves CAR-M activity against solid tumors
by: Sumiti Jain, et al.
Published: (2023-11-01) -
Cognitive Impairments Preceding and Outlasting Autoimmune Limbic Encephalitis
by: Robert Gross, et al.
Published: (2016-01-01) -
442 CAIX targeted CAR-T cells exhibited antitumor efficacy on renal cell carcinoma (RCC) patient derived organotypic tumor spheroids (PDOTS)
by: Sabina Signoretti, et al.
Published: (2023-11-01) -
442-I Enhancing TCR-T responses and overcoming the tumor microenvironment by combination with a TGFβ-specific CAR
by: Ximin Chen, et al.
Published: (2023-11-01) -
442-G Metabolic reprogramming regulates anti-tumor effects of engineered CAR/TCR T cells
by: Xiaoyu Zhang, et al.
Published: (2023-11-01)